Results 251 to 260 of about 228,880 (307)

Recent advances in CRISPR technologies for biomedical applications and disease treatment. [PDF]

Theranostics
Wu X, Kou X, Bai L, Liu C, Wu Q, Zhang M, Wang N, Gong C.   +7 more
europepmc   +1 more source

Statement of Retraction: CRISPR/Cas9 (D10A) nickase-mediated Hb CS gene editing and genetically modified fibroblast identification. [PDF]

Bioengineered
europepmc   +1 more source

ZNF292 mutations impair RNA and protein biosynthesis defining an adverse prognostic subset in early-stage chronic lymphocytic leukemia. [PDF]

Biomark Res
Rodríguez-Sánchez A, Alonso-Gago M, Pérez-Carretero C, Corchete-Sánchez LA, Miguel-García C, Santos-Minguez S, Villaverde-Ramiro Á, Queizán-Hernandez JA, Rubio A, Benito-Sánchez R, Schiavo FL, Ghetti M, Simonetti G, Rodríguez-Vicente AE, Hernández-Rivas JM, Quijada-Álamo M.   +15 more
europepmc   +1 more source

Clonal Analysis in <i>Drosophila</i> Tissues With an Enhanced MAGIC Transgenesis Method. [PDF]

Bio Protoc
Shen Y, Han C.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

CRISPR/Cas9

2023
CRISPR/Cas9 is the genome-editing technology that is most widely used around the world. Its widespread adoption is largely due to its simplicity and ease of use. Here, we introduce the construction of vectors and genome editing of the target gene in cells using the CRISPR/Cas9 system.
Izuho, Hatada, Sumiyo, Morita, Takuro, Horii   +2 more
openaire   +3 more sources